Table 4 Description of the parameters of interest in the Overall population and in the long-term survivor population (>48 months and >72 months)
Patients Characteristics | Overall population (N =390) | Long-term survivor (>48 months) (N =67) | Long-term survivor (>72 months) (N =28) | ||||
|---|---|---|---|---|---|---|---|
N | N | N | |||||
Conventional parameters | Lymph Nodes ratio | 380 | 67 | 28 | |||
< 0.2 | 279 (73 %) | 59 (88 %) | 27 (96 %) | ||||
≥ 0.2 | 104 (27 %) | 8 (12 %) | 1 (4 %) | ||||
Vascular invasion | 361 | 65 | 28 | ||||
No | 242 (67 %) | 51 (78 %) | 23 (82 %) | ||||
Yes | 119 (33 %) | 14 (22 %) | 5 (18 %) | ||||
Adjuvant Chemotherapy— no. (%) | 336 | 58 | 22 | ||||
No | 85 (25 %) | 6 (10 %) | 3 (14 %) | ||||
Yes | 251 (75 %) | 52 (90 %) | 19 (86 %) | ||||
Lymphopenia parameters | Pre-operative lymphocyte count | 390 | 1320 (150–8350) | 67 | 1330 (390–3360) | 28 | 1350 (560–2970) |
Post-operative lymphocyte count | 301 | 1410 (200–32000) | 57 | 1600 (930–3620) | 24 | 1589 (940–2976) | |
Pre-operative lymphocyte count | 390 | 67 | 28 | ||||
≤ 1000 | 110 (28 %) | 11 (16 %) | 6 (21 %) | ||||
> 1000 | 280 (72 %) | 56 (84 %) | 22 (79 %) | ||||
Post-operative lymphocyte count | 299 | 57 | 24 | ||||
≤ 1000 | 65 (22 %) | 3 (5 %) | 1 (4 %) | ||||
> 1000 | 236 (78 %) | 54 (95 %) | 23 (96 %) | ||||
Lymphocyte count pre and post combined | 301 | 57 | 24 | ||||
> 1000/>1000 | 182 (60 %) | 46 (81 %) | 18 (75 %) | ||||
≤ 1000/>1000 | 54 (18 %) | 8 (14 %) | 5 (21 %) | ||||
> 1000/≤1000 | 37 (12 %) | 2 (4 %) | 1 (4 %) | ||||
≤ 1000/≤1000 | 28 (10 %) | 1 (2 %) | 0 (0 %) | ||||